Mirae Asset Global Investments Co., Ltd. Kodiak Sciences Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$3.01 - $7.45 $41,935 - $103,793	13,932 New	13,932 $73,000
Q2 2023 Aug 10, 2023	SELL	$4.3 - $9.48 $455 - $1,004	-106 Reduced 0.7%	15,116 $104,000
Q1 2023 May 04, 2023	SELL	$4.81 - $8.88 $163 - $301	-34 Reduced 0.22%	15,222 $94,000
Q4 2022 Feb 09, 2023	BUY	$6.52 - $8.05 $163 - $201	25 Added 0.16%	15,256 $109,000
Q3 2022 Nov 10, 2022	BUY	$7.57 - $12.5 $31,975 - $52,800	4,224 Added 38.38%	15,231 $118,000
Q2 2022 Jul 26, 2022	BUY	$5.04 - $9.48 $55,475 - $104,346	11,007 New	11,007 $84,000
Q1 2022 May 10, 2022	SELL	$7.09 - $89.45 $82,123 - $1.04 Million	-11,583 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$80.85 - $128.49 $2,344 - $3,726	-29 Reduced 0.25%	11,583 $982,000
Q3 2021 Nov 15, 2021	BUY	$81.97 - $106.94 $93,035 - $121,376	1,135 Added 10.83%	11,612 $1.12 Million
Q2 2021 Aug 11, 2021	BUY	$77.2 - $126.54 $178,949 - $293,319	2,318 Added 28.41%	10,477 $974,000
Q1 2021 May 13, 2021	BUY	$110.45 - $164.47 $114,205 - $170,061	1,034 Added 14.51%	8,159 $925,000
Q4 2020 Feb 10, 2021	BUY	$60.78 - $154.03 $433,057 - $1.1 Million	7,125 New	7,125 $1.05 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.